Biming conducts scientific and commercial analysis of medical technology assets.
Prior to joining RTW, Biming was a research fellow at the Regeneron Genetics Center. His research focused on developing algorithms and building machine learning tools to analyze large-scale biomedical datasets and aid drug discovery.
Biming received a PhD in Biomedical Engineering from the University of Michigan, where he developed synthetic biology tools and biomaterials for orthopedic applications. He also has a BS in Chemical Engineering from the University of Iowa.
Every day, advances in science, technology, and engineering redefine the limits of medical innovation. I am excited to be part of a team that helps accelerate the development of revolutionary clinical tools and solutions.